PCOS is now PMOS
Why PCOS is being renamed PMOS, and what it means for you.
From ₹1,490 · sample collected at home

You've probably seen it: PCOS is being called by a new name - PMOS. It's real. In May 2026, after more than a decade of work, a global coalition of medical and patient organisations officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS).
The condition itself hasn't changed - only its name has, and with good reason. Here's what PMOS means, why the change happened, and what it does (and doesn't) mean for you.
PMOS is Polyendocrine Metabolic Ovarian Syndrome. The new name leads with hormones ('polyendocrine') and recognises the metabolic side of the condition - a more accurate description than 'polycystic'.
The old name could be misleading: many women with the condition don't have ovarian cysts, and 'polycystic' underplayed its hormonal and metabolic nature. Experts felt the name contributed to delayed diagnosis over the years.
The rename was led by Professor Helena Teede at Monash University, after 14 years of work with patients and clinicians around the world, and involved 56 patient and professional organisations, including the Endocrine Society. It was published in The Lancet on 12 May 202600717-8/fulltext) and announced by the Endocrine Society.
A three-year transition has begun. You'll see both names used side by side, and the new name is due to be fully adopted in the 2028 update of the international PCOS guideline. Until then, most doctors, reports and searches will still say PCOS.
Whether you call it PCOS or PMOS, our gynaecologists care for it the same way - around your hormones, metabolism and symptoms.
We keep pace with how the condition is understood and named, so your care reflects current best practice.
We explain what the name change means for you in plain language - no jargon, no scare.
PCOS Assessment
₹1,490
A gynaecologist consult and the tests your symptoms need, collected at home.
Yes. In May 2026 a global consensus led by Monash University's Professor Helena Teede, involving 56 patient and professional organisations including the Endocrine Society, renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). It was published in The Lancet on 12 May 2026, with a three-year transition to the new name.
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. The name reflects the condition's hormonal (endocrine), metabolic and ovarian nature more accurately than the older term 'polycystic ovary syndrome'.
Because 'polycystic ovary syndrome' could be misleading - many women with it don't have cysts, and the name underplayed its hormonal and metabolic core, which experts felt contributed to delayed diagnosis. The new name is more accurate.
No. It's the same condition - your diagnosis, tests and treatment don't change. You'll simply see the name PMOS used more over time, alongside PCOS during the transition.
Yes, for now. Most information, doctors and patients still use 'PCOS', and it remains widely recognised. PMOS is the new official name, and both are being used side by side while the change settles in.
Read more

Two women with the same PCOS/PMOS diagnosis can look nothing alike. There are four recognised phenotypes (A, B, C, D), and which one you have changes your symptoms, your risks and your treatment. Here is how to work out where you fit.
Read article
Insulin resistance is the engine behind most PCOS/PMOS - and it can run for years while a standard blood-sugar test reads perfectly normal. Here is how it drives your symptoms, the tests that actually catch it, and what improves it.
Read articleKeep reading
PCOS Assessment, ₹1,490. Home lab tests, then your consult.
This page is educational and not a substitute for individual medical advice. Any diagnosis or prescription is made only by your treating clinician based on your case. *Timelines depend on collection and lab processing. Individual results vary. Terms apply.